DNLI - CIK 0001714899
As of 2026-06-10, Denali Therapeutics Inc. (DNLI) has a market capitalization of $3.27 B, making it the #1734 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-10 | $3.27 B |
| 2026-05-29 | $3.35 B |
| 2026-05-28 | $3.21 B |
| 2026-05-26 | $3.11 B |
| 2026-05-25 | $2.96 B |
| 2026-05-24 | $2.96 B |
| 2026-05-22 | $2.96 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-10, Denali Therapeutics Inc. (DNLI) has a market capitalization of $3.27 B, making it the #1734 most valuable US-listed company.
Denali Therapeutics Inc. is the #1734 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.